Data from numerous clinical trials primarily evaluating the antihyperglycemic effects of multiple GLP-1 RAs have also revealed that changes in most CVD risk markers reported as secondary outcomes have been in favor of GLP-1 RAs treatment
How weight-loss medications evolved from short-term tools to ongoing treatment The short-term era Before GLP-1s became the weight-loss drug du jour, there was fen-phen a diet-drug craze whose name alone is enough to spark instant recognition, unease and a fair amount of Wait, I cant believe that was a thing. The off-label combination paired phentermine with fenfluramine, both stimulants, and became widely used in the '90s
I've lost 280 pounds
It also disburses energy at cellular level
We often blame the healthcare system (and obviously it can improve in many ways) but its playing whack-a-mole with chronic disease downstream of an entire economy based on delicious, cheap, convenient, and often ultra-processed food
Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity